Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: Belgium Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20131
20151
20161
20171
20182
20192
20211
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Merus B.V.2
BicycleTx Limited1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Daiichi Sankyo1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1
Genmab1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck18
Carcinoma, Non-Small-Cell Lung6
Uterine Cervical Neoplasms6
Colorectal Neoplasms5
Head and Neck Neoplasms5
Ovarian Neoplasms5
Stomach Neoplasms5
Triple Negative Breast Neoplasms5
Endometrial Neoplasms4
Melanoma4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.